Caricamento...

End points and statistical considerations in immuno-oncology trials: impact on multiple myeloma

Unlike conventional cancer treatment, immuno-oncology therapies are commonly associated with delayed clinical benefit and durable responses, as seen with immuno-oncology therapies for multiple myeloma (MM). Therefore, a longer-term approach to immuno-oncology data assessment is required. Appropriate...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Future Oncol
Autori principali: Hoering, Antje, Durie, Brian, Wang, Hongwei, Crowley, John
Natura: Artigo
Lingua:Inglês
Pubblicazione: Future Medicine Ltd 2017
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5705823/
https://ncbi.nlm.nih.gov/pubmed/28395525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon-2016-0504
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !